Literature DB >> 20035859

Methamphetamine sensitization attenuates the febrile and neuroinflammatory response to a subsequent peripheral immune stimulus.

J B Buchanan1, N L Sparkman, R W Johnson.   

Abstract

Methamphetamine (MA) use is associated with activation of microglia and, at high doses, can induce neurotoxicity. Given the changes in the neuroinflammatory environment associated with MA, we investigated whether MA sensitization, a model of stimulant psychosis and an indicator of drug addiction, would interfere with the thermoregulatory and neuroinflammatory response to a subsequent peripheral immune stimulus. C57BL6/J mice were given either 1 mg/kg MA or saline i.p. once a day for 5 days to produce behavioral sensitization. Seventy-two hours following the last MA injection, 100 microg/kg LPS or saline was co-administered with 1 mg/kg MA or saline and blood and brains were collected. Here we report that while co-administration of LPS and MA did not affect the LPS-induced increase in central cytokine mRNA, mice sensitized to MA showed an attenuated central response to LPS. Interestingly, the peripheral response to LPS was not affected by MA sensitization. Plasma cytokines increased similarly in all groups after LPS. Further, c-Fos expression in the nucleus of the solitary tract did not differ between groups, suggesting that the periphery-to-brain immune signal is intact in MA-sensitized mice and that the deficit lies in the central cytokine compartment. We also show that MA sensitization decreased LPS- or acute MA-induced microglial Iba1 expression compared to non-sensitized mice. Taken together, these data show that MA sensitization interferes with the normal central immune response, preventing the CNS from efficiently responding to signals from the peripheral immune system. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035859      PMCID: PMC2834480          DOI: 10.1016/j.bbi.2009.12.008

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  42 in total

1.  Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters.

Authors:  Yohtaro Numachi; Arihisa Ohara; Motoyasu Yamashita; Setsu Fukushima; Hideaki Kobayashi; Harumi Hata; Hidekazu Watanabe; F Scott Hall; Klaus-Peter Lesch; Dennis L Murphy; George R Uhl; Ichiro Sora
Journal:  Eur J Pharmacol       Date:  2007-06-27       Impact factor: 4.432

2.  Exacerbated glial response in the aged mouse hippocampus following controlled cortical impact injury.

Authors:  Rajat Sandhir; Gregory Onyszchuk; Nancy E J Berman
Journal:  Exp Neurol       Date:  2008-07-02       Impact factor: 5.330

3.  Methamphetamine injection independently predicts hepatitis C infection among street-involved youth in a Canadian setting.

Authors:  Cari L Miller; Thomas Kerr; Benedikt Fischer; Ruth Zhang; Evan Wood
Journal:  J Adolesc Health       Date:  2008-11-06       Impact factor: 5.012

4.  Protective effects of interferon-gamma against methamphetamine-induced neurotoxicity.

Authors:  Hiroaki Hozumi; Masato Asanuma; Ikuko Miyazaki; Saki Fukuoka; Yuri Kikkawa; Naotaka Kimoto; Yoshihisa Kitamura; Toshiaki Sendo; Taizo Kita; Yutaka Gomita
Journal:  Toxicol Lett       Date:  2008-01-17       Impact factor: 4.372

5.  The effects of methamphetamine on core body temperature in the rat--part 1: chronic treatment and ambient temperature.

Authors:  Benita J Myles; Lee Ann Jarrett; Susan L Broom; H Anton Speaker; Karen E Sabol
Journal:  Psychopharmacology (Berl)       Date:  2008-04-27       Impact factor: 4.530

6.  The effects of methamphetamine on core body temperature in the rat--part 2: an escalating regimen.

Authors:  Benita J Myles; Karen E Sabol
Journal:  Psychopharmacology (Berl)       Date:  2008-04-26       Impact factor: 4.530

7.  Methamphetamine causes microglial activation in the brains of human abusers.

Authors:  Yoshimoto Sekine; Yasuomi Ouchi; Genichi Sugihara; Nori Takei; Etsuji Yoshikawa; Kazuhiko Nakamura; Yasuhide Iwata; Kenji J Tsuchiya; Shiro Suda; Katsuaki Suzuki; Masayoshi Kawai; Kiyokazu Takebayashi; Shigeyuki Yamamoto; Hideo Matsuzaki; Takatoshi Ueki; Norio Mori; Mark S Gold; Jean L Cadet
Journal:  J Neurosci       Date:  2008-05-28       Impact factor: 6.167

8.  Exacerbated fatigue and motor deficits in interleukin-10-deficient mice after peripheral immune stimulation.

Authors:  C P Krzyszton; N L Sparkman; R W Grant; J B Buchanan; S R Broussard; J Woods; R W Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-23       Impact factor: 3.619

9.  Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges.

Authors:  Devon L Graham; Pierre-A H Noailles; Jean Lud Cadet
Journal:  J Neurochem       Date:  2008-02-01       Impact factor: 5.372

10.  A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse.

Authors:  W E Fantegrossi; J R Ciullo; K T Wakabayashi; R De La Garza; J R Traynor; J H Woods
Journal:  Neuroscience       Date:  2007-11-17       Impact factor: 3.590

View more
  13 in total

1.  Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1β mRNA expression in the hypothalamus.

Authors:  Michael J Seminerio; Matthew J Robson; Christopher R McCurdy; Rae R Matsumoto
Journal:  Eur J Pharmacol       Date:  2012-07-20       Impact factor: 4.432

2.  Effect of aspartame on oxidative stress and monoamine neurotransmitter levels in lipopolysaccharide-treated mice.

Authors:  Omar M E Abdel-Salam; Neveen A Salem; Jihan Seid Hussein
Journal:  Neurotox Res       Date:  2011-08-06       Impact factor: 3.911

3.  Microglial activation and responses to vasculature that result from an acute LPS exposure.

Authors:  John F Bowyer; Sumit Sarkar; Susan M Burks; Jade N Hess; Serena Tolani; James P O'Callaghan; Joseph P Hanig
Journal:  Neurotoxicology       Date:  2020-01-31       Impact factor: 4.294

Review 4.  Neuroimmune basis of methamphetamine toxicity.

Authors:  Jennifer M Loftis; Aaron Janowsky
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

Review 5.  Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.

Authors:  Jennifer M Loftis; Marilyn Huckans
Journal:  Pharmacol Ther       Date:  2013-04-28       Impact factor: 12.310

6.  A neurotoxic regimen of methamphetamine exacerbates the febrile and neuroinflammatory response to a subsequent peripheral immune stimulus.

Authors:  Jessica B Buchanan; Nathan L Sparkman; Rodney W Johnson
Journal:  J Neuroinflammation       Date:  2010-11-22       Impact factor: 8.322

7.  Luteolin inhibits behavioral sensitization by blocking methamphetamine-induced MAPK pathway activation in the caudate putamen in mice.

Authors:  Tinglin Yan; Lu Li; Baiyu Sun; Fei Liu; Peng Yang; Teng Chen; Tao Li; Xinshe Liu
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

8.  Systemic immune activation leads to neuroinflammation and sickness behavior in mice.

Authors:  Steven Biesmans; Theo F Meert; Jan A Bouwknecht; Paul D Acton; Nima Davoodi; Patrick De Haes; Jacobine Kuijlaars; Xavier Langlois; Liam J R Matthews; Luc Ver Donck; Niels Hellings; Rony Nuydens
Journal:  Mediators Inflamm       Date:  2013-07-10       Impact factor: 4.711

9.  Early life overfeeding impairs spatial memory performance by reducing microglial sensitivity to learning.

Authors:  Simone N De Luca; Ilvana Ziko; Luba Sominsky; Jason C D Nguyen; Tara Dinan; Alyson A Miller; Trisha A Jenkins; Sarah J Spencer
Journal:  J Neuroinflammation       Date:  2016-05-18       Impact factor: 8.322

10.  Exercise protects against methamphetamine-induced aberrant neurogenesis.

Authors:  Minseon Park; Harry Levine; Michal Toborek
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.